Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CS Diagnostics Pharma is an international pharmaceutical wholesaler and manufacturer of medical technology and pharmaceutical products headquartered in Germany. As a key component of the CS Group, the company develops and commercializes innovative healthcare solutions, including medical devices for radiology and radiotherapy. Its flagship products include the CS-Protect Hydrogel, a tissue spacer designed to protect healthy organs during prostate cancer radiotherapy, and the MEDUSA smart disinfectant platform. Additionally, the company provides global wholesale services, supplying clinics, specialists, and health ministries with a broad range of medicines and medical supplies. CS Diagnostics Pharma maintains a strong presence in the DACH and MENA regions while expanding its regulatory footprint in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CS Diagnostics Pharma.